Healthcare Sector

PFE

Market Tracker

$24.37
+0.07
(+0.29%)
5:40 am
Next Earnings: (est.) 08/01/23 12:00 am
  • PFE (Selected)

    Pfizer Inc.
  • PFEB

    Innovator S&P 500 Power Buffer ETF - February

PFE Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

PFE Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PFE Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PFE Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

PFE Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PFE Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
08/15/2025 PUT $23.50 2,961 +2,736 +1,216.00%
12/18/2026 CALL $40.00 16,654 +2,632 +18.77%
08/08/2025 PUT $24.00 4,656 +2,048 +78.53%
08/01/2025 PUT $24.00 6,142 +1,773 +40.58%
08/01/2025 CALL $24.50 2,409 +1,771 +277.59%
08/01/2025 PUT $24.50 5,348 +1,646 +44.46%
09/19/2025 CALL $30.00 13,967 -79 -0.56%
09/19/2025 CALL $27.00 25,757 -108 -0.42%
12/19/2025 PUT $35.00 1,627 -193 -10.60%
11/21/2025 CALL $27.00 10,775 -246 -2.23%
12/19/2025 PUT $32.50 6,949 -1,496 -17.71%
01/16/2026 PUT $32.50 5,848 -2,502 -29.96%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PFE Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.02% 170.64M 6.14B
Vanguard 500 Index Fund 2.30% 129.76M 4.67B
Washington Mutual Investors Fund 1.42% 80.41M 2.89B
Fidelity 500 Index Fund 1.09% 61.54M 2.21B
SPDR S&P 500 ETF Trust 1.08% 60.77M 2.19B
American Balanced Fund 1.00% 56.61M 2.04B
Income Fund of America Inc 0.93% 52.68M 1.9B
iShares Core S&P 500 ETF 0.89% 50.1M 1.8B
Vanguard Index-Value Index Fund 0.86% 48.51M 1.75B
Vanguard Specialized-Health Care Fund 0.86% 48.32M 1.74B

PFE News

  • Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections

    07/29 01:15 am

    GlobeNewswire Inc.

    Read more
  • Basilea initiiert Phase-3-Studie mit Antipilzmittel Fosmanogepix bei invasiven Schimmelpilzinfektionen

    07/29 01:15 am

    GlobeNewswire Inc.

    Read more
  • Global Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032 | DelveInsight

    07/23 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade

    07/21 08:15 am

    The Motley Fool

    Read more
  • Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?

    07/20 09:25 am

    The Motley Fool

    Read more
  • 2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 Right Now

    07/19 04:27 am

    The Motley Fool

    Read more
  • 4 High-Yield Large-Caps With Dividend Risk and Opportunity in Focus

    07/16 02:11 pm

    Investing.com

    Read more
  • This Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a Comeback

    07/16 04:12 am

    The Motley Fool

    Read more
  • Pfizer Faces $1 Billion IRA Reform Hit As Analysts Expect Flat 2025 Outlook

    07/14 02:39 pm

    Benzinga

    Read more
  • Functional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong

    07/11 04:21 am

    GlobeNewswire Inc.

    Read more
  • Burn Pain Market Report 2025-2035 | Focus on Treatment Type, Burn Type, and Country Analysis

    07/11 04:20 am

    GlobeNewswire Inc.

    Read more
  • Burns Market Analysis and Forecast Report 2025-2035 Featuring Pfizer, Perrigo, Kenvue Brands, 3M, Smith+Nephew, Molnlycke, Cardinal Health, Convatec, Haleon, Coloplast, DeRoyal Industries

    07/11 04:19 am

    GlobeNewswire Inc.

    Read more
  • Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development

    07/10 04:00 am

    GlobeNewswire Inc.

    Read more
  • This Is the No. 1 Ultra-High-Yield Dividend Stock Held by Retail Investors on Robinhood -- and It's Not Even Close

    07/10 03:06 am

    The Motley Fool

    Read more
  • The Best Dividend Stocks I'd Buy Right Now

    07/05 06:30 am

    The Motley Fool

    Read more
  • Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

    07/04 04:30 am

    The Motley Fool

    Read more
  • Microservices in Healthcare Market Size to Hit USD 1,905.26 Million by 2032, Driven by Cloud Adoption and Healthcare Digitization – SNS Insider

    06/28 08:00 am

    GlobeNewswire Inc.

    Read more
  • Want to Collect $2,000 in Dividends Each Year? Here's How Much You Should Aim to Invest in the Stock Market Today.

    06/27 04:22 am

    The Motley Fool

    Read more
  • Flu RNA Vaccines Market Research Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges

    06/20 10:59 am

    GlobeNewswire Inc.

    Read more
  • BioNTech’s CureVac Deal Signals Deep Pivot Toward mRNA Cancer Therapies

    06/13 11:41 am

    Investing.com

    Read more
  • Rheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies

    06/10 04:53 am

    GlobeNewswire Inc.

    Read more
  • Selective Estrogen Receptor Modulators Market Research 2025-2030: Leading Players Shaping the Future of Selective Estrogen Receptor Modulators Industry

    06/09 04:56 am

    GlobeNewswire Inc.

    Read more
  • Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)

    06/06 07:00 am

    GlobeNewswire Inc.

    Read more
  • Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

    06/06 07:00 am

    GlobeNewswire Inc.

    Read more
  • Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis

    06/05 03:34 am

    The Motley Fool

    Read more
  • Here Are All 6 Stocks I've Bought Through 5 Months of 2025

    06/05 03:06 am

    The Motley Fool

    Read more
  • Starke Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen weitere Meilensteinzahlung an Basilea aus

    06/05 01:15 am

    GlobeNewswire Inc.

    Read more
  • Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea

    06/05 01:15 am

    GlobeNewswire Inc.

    Read more
  • 3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June

    06/03 03:06 am

    The Motley Fool

    Read more
  • CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    06/02 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Terrible News for Pfizer Stock Investors

    06/01 09:15 am

    The Motley Fool

    Read more
  • Beat the S&P 500 With This Cash-Gushing Dividend Stock

    06/01 04:14 am

    The Motley Fool

    Read more
  • The World Market for Smoking Cessation & Nicotine De-Addiction Products 2025-2030: Precision Counseling, Targeted Pharmacogenomic Therapies, and Resilient Supply Chains Present Lucrative Opportunities

    05/30 04:56 am

    GlobeNewswire Inc.

    Read more
  • Pfizer's Mega Deal Highlights China's Rising Role In Global Pharma

    05/29 09:38 am

    Benzinga

    Read more
  • Novo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market?

    05/28 04:15 am

    The Motley Fool

    Read more
  • Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight

    05/27 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Schizophrenia Drugs Market Research Report 2025-2035: Advances in Antipsychotic Drug Development, Increasing Prevalence, & Greater Awareness and Access to Mental Health Care Bolster Growth

    05/27 10:56 am

    GlobeNewswire Inc.

    Read more
  • Madison Realty Capital Originates $720 Million Loan for Office-to-Residential Conversion of Former Pfizer Headquarters

    05/25 06:00 pm

    GlobeNewswire Inc.

    Read more
  • Investing for Passive Income? Here's What History Says About the Stability of Dividend King Stocks.

    05/25 04:10 am

    The Motley Fool

    Read more
  • U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

    05/24 04:11 am

    The Motley Fool

    Read more
  • Pfizer's 7.5% Dividend: Income Haven or House of Cards?

    05/23 05:11 pm

    Investing.com

    Read more
  • CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    05/23 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - Trump Tariffs Drive Pharma Manufacturing to US but Risk Inflation and Disruption

    05/19 10:56 am

    GlobeNewswire Inc.

    Read more
  • Iterum Therapeutics Announces Extension of Term of Promissory Note

    05/19 07:00 am

    GlobeNewswire Inc.

    Read more
  • Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.

    05/18 12:05 pm

    The Motley Fool

    Read more
  • 3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever

    05/14 06:05 pm

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: